Induction and inhibition of cytochrome P-450* [PDF]
Induction and inhibition of cytochrome P-450*
Pelkonen, Olavi
core
Factors Influencing Phenoconversion in CYP-Mediated Drug Metabolism: A Scoping Review. [PDF]
Scodellaro S, Triantafilou S, Cohn I.
europepmc +1 more source
CYP2D6 Metabolizer Status and Mortality in Metoprolol Users. [PDF]
de Denus S +11 more
europepmc +1 more source
Response to "Comment on cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults - results from the ActiFE study". [PDF]
Lorenz L +6 more
europepmc +1 more source
Pharmacogenomic-Guided Prescribing for Treatment-Resistant Mental Health Conditions in Australian Primary Care: A Single-GP Practice Retrospective Observation of 29 Patients. [PDF]
Beer C +4 more
europepmc +1 more source
Cytochrome P-450 in drug-resistant Mycobacterium tuberculosis
Methods for the isolation and spectrophotometric determination of cytochrome P-450 in mycobacteria were standardized. Cytochrome P-450 levels were estimated in Mycobacterium tuberculosis organisms sensitive to both isoniazid and rifampicin and resistant ...
Gurumurthy, Prema +3 more
core
Pharmacokinetic Drug-Drug Interactions of Imlunestrant in Healthy Female Participants of Nonchildbearing Potential. [PDF]
Datta-Mannan A +5 more
europepmc +1 more source
Effects of Celecoxib and Etoricoxib on the Pharmacokinetics and Pharmacological Effects of Orally Administered Tramadol: A Randomised Controlled Trial. [PDF]
Saarikoski T +6 more
europepmc +1 more source
Association of Selected Genetic Variants in CYP1A1, CYP2D6, NAT1 and NAT2 with Endometrial Cancer Risk: A Preliminary Case-Control Study. [PDF]
Skrzypek M +5 more
europepmc +1 more source
CYP2D6 Genotypes Do Not Affect Clozapine Levels in a Large, Multicenter Cohort: Time Has Come to Revise Food and Drug Administration's Clozapine Packet Insert. [PDF]
Schoretsanitis G +16 more
europepmc +1 more source

